China Trends To Watch: Reform And Approvals Accelerate, Costs Slow
This article was originally published in The Tan Sheet
Executive Summary
From increasing new drug approval efficiency to pricing relaxation to allowing physicians to work in multiple locations, more regulatory changes are coming in China, which is likely to make 2015 a volatile year for drug makers in the country.